chrisvoncsefalvay/vaers-outcomes huggingface dataset:
stomach aches; I was sick for a day; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach aches), ILLNESS (I was sick for a day) and NAUSEA (Nauseous) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach aches), ILLNESS (I was sick for a day) and NAUSEA (Nauseous). At the time of the report, ABDOMINAL PAIN UPPER (stomach aches), ILLNESS (I was sick for a day) and NAUSEA (Nauseous) had resolved.            No concomitant medications were reported No treatment medications were reported
Devel fever 103.9 ax w/in 1 hr of receiving vax; vomited yellow liquid 2x; anorexic, nauseated, lethargic & very irritable x 2 days; tx APAP, cool applications, rest;
Patient presented with a large deep purple bruise at the injection site. Bruise had splotches of red throughout. Patient reported he was stabbed twice for one vaccine.
ADMINISTERED VACCINE STORED OUTSIDE RECOMMENDED CONDITIONS (POOR QUALITY DRUG ADMINISTERED); OFF LABEL USE; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned multiple patients. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, the patient experienced administered vaccine stored outside recommended conditions (poor quality drug administered), off label use, and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administered vaccine stored outside recommended conditions (poor quality drug administered), off label use and incorrect product storage was not reported. This report was non-serious.
Within three hours , started having chills and later in the night 2200 , generalised weakness. next Morning 08/20/21 ,Unable to lift arm above head and soreness , no appetie , chills, mucous drainage and weakness and as the day progressed diarrhea X3 . 08/21/21 still having chills but to a lesser degree, no appettite,  weakness ( improved but slightly) , mucus drainage fron throat
I started with redness, very sore to touch, a hard knot and hot to touch around and below the injection site.  I took some ibuprofen and cold compresses to the site.  It went away for a couple of days and then returned with the same symptoms.  It is still there as of today, but the knot is gone.  I just have redness and heat to that area.
Information has been received from a health professional concerning a 60 year old white female who on 03/31/2003 was vaccinated in the left arm with a 0.5ml dose of pneumococcal vaccine 23 polyvalent (Lot # 644218/1027M).  On approximately 03/31/2003, the patient developed a fever, swelling, a sore area hot to the touch that was hard with bruising and a big lump.  On approximately 04/02/2003, "a couple of days later", the patient recovered after being treated with unspecified antibiotics.  It was also noted that an 82 year old male patient was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot # 64421/1027M) and developed the same symptoms (WAES # 0304USA01006).  No further information is expected.
met 2 people who are having issues after receiving the Moderna COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (met 2 people who are having issues after receiving the Moderna COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (met 2 people who are having issues after receiving the Moderna COVID-19). At the time of the report, VACCINATION COMPLICATION (met 2 people who are having issues after receiving the Moderna COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment details not provided.
12:20 pm - vaccination 2:20pm - Most severe headache i've ever experienced, Rash on both arms and legs. 8:30pm -  severe fever(101.7) with chills and body ache Tylenol 975 mg taken 9/11/21, 3:30am . Woke with severe night sweats, chills and fever tylenol taken again. 10am -   rash still visible on arms and leg. fatigue and weak persistent headache 12 noon -  tylenol taken for headache 9pm went to sleep woke up at 12:30 am 9/12/21. severe chills night sweats and fever. tylonol975mg taken 9/12/21 continue tylenol every 6-8 hours as needed. weak dizzy activity intolerance SOB upon activity. Unable to go to work called out sick. reported adverse reaction to VAERS.
Persistent lymphadenopathy. Deep axillary lymph nodes in Left arm.  Palpable, sensitive/sometimes painful to palpation. Began after Dose #2 (March 2021). Still ongoing as of today (October 14, 2021).  Has lasted for 7 months and symptoms remain unchanged.
Pt recv vax on 10/15/98; on 10/16/98 pt exp redness, warmth, raised, itchy, stinging around injection site &below site.
Beginning the day after, pt had mild bruising over injection site. Over the next several days, bruising darkened and extended from superior L shoulder to elbow.
Client approached EMT reporting "head pressure, hand shaking, and mild nausea." The client ambulated unassisted with a steady gait and sat down in the anti-gravity chair. The client began drinking water provided by staff. The client states she last ate at 1:00 PM. Vitals obtained at 4:35PM were as follows: automatic BP 140/69, HR 98, O2 99%. The client denied any other s/s of anaphylaxis. The client stated her head pressure and nausea had resolved. RN noted mild shaking of the client's hand when the client held her hand out in front of her body. The client denied any history of anxiety. No chronic conditions or medications. The client has no known allergies. Repeat vitals obtained at 4:40PM were as follows: automatic BP 134/75, HR 102, and O2 100%. RN asked the client if she was experiencing any symptoms. The client responded, "no, just the hand." RN noted mild shaking of the client's right hand. Vitals obtained at 4:50PM were as follows: automatic BP 124/72, HR 81, O2 99%. The client denied any symptoms and stated her hand shaking had resolved. RN noted no shaking of the client's left hand. RN educated the client regarding s/s of anaphylaxis and when to seek EMS. The client voiced understanding of this education. RN recommend the client stay in the observation area for another 10 minutes. The client voiced understanding of this education, but elected to leave. The client stated "I feel normal." Client left observation area unassisted with a steady gait at 4:53PM.
This spontaneous report was received from a registered nurse and refers to a 5-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 18-DEC-2018, the patient was vaccinated with improperly stored dose of VAQTA lot # R018935, expiration date 05-SEP-2019 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (It was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000071.
Body aches; Tiredness; Slight headache; This is a spontaneous report from a Non-contactable Other-HCP reported for self. This 23-year-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Jan2021 16:30 PM on Arm left at single dose for covid-19 immunisation. Medical history included GERD, Barrett's esophagus. No Known allergies. No covid prior vaccination. Concomitant medications included omeprazole for Birth control, hydroxyzine for Birth control, sertraline for birth control. She experienced Body aches, tiredness, slight headache on 22Jan2021. No covid tested post vaccination. No treatments were received. Outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sour taste in my mouth; Nausea; Vomit a few times; Sick to my stomach; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Sick to my stomach), DYSGEUSIA (Sour taste in my mouth), NAUSEA (Nausea) and VOMITING (Vomit a few times) in a not specif patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medication report were provided).    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Sick to my stomach). On 29-Mar-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomit a few times). On 30-Mar-2021, the patient experienced DYSGEUSIA (Sour taste in my mouth). At the time of the report, ABDOMINAL DISCOMFORT (Sick to my stomach), DYSGEUSIA (Sour taste in my mouth), NAUSEA (Nausea) and VOMITING (Vomit a few times) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
3.30.21 vasovagal syncope, dyspnea during jiujitsu.  General fatigue, thought from vaccine. 4.1.21 same 4.3.21 same 4.6.21 same 4.8.21 same 4.11.21 same but during boxing 4.12.21 same but during jumping rope 4.13.21 second vaccine Pfizer same clinic at 12:00pm ER2613 4.14.21 same but during boxing 4.15.21 same but during, boxing, jumping rope, and rowing 4.18.21 same but during bike ride and walking 4.19.21 same but during coaching 4.20.21 admitted to ED 4.22.21 diagnosed with third degree heart block and dual chamber pacer fitted 4.23.21 DC
Approx 30 min p/DTP pt became limp, "jittery", head felt hot & body from neck down was cold; rapid side to side eye movements under closed eyelids; afterwards was trembling; obtunded but could be aroused; stupor, crying, teeth clenched;
Silver dollar raised red knot tender to the touch on back of arm. Itchy very tender.
Hives, itching, wheezing, tachycardia, high b/p, difficulty breathing
12/27/05 child woke up with 30+ chicken pox lesions.  Had Varivax 9/13/01.  Mom gave Benadryl.  Child recovered from incident.
Left upper arm with swelling, erythema, fairly sharply demarcated. Treatment: recommend elevation, cool compresses, Advil, mother to follow for hand swelling, fever, capillary refill of the nailbed.
HCP calling to report AE related to Temp Excursion; No additional AE.; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age or gender. The patient's concurrent conditions, medical history, and concomitant medications were not provided.   On an unspecified date, a call was received stating that a temperature excursion (Product storage error) had occurred; however, it was unknown the date of administration. It was reported that the patient had received either varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number valid, reported as W039294, expiration date 11-DEC-2024) or measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (recombinant Human albumin) (PROQUAD) (lot number valid, reported as X002105, expiration date 18-JUL-2024); both administered for prophylaxis (doses, routes of administrations and anatomical locations, were not provided).  The vaccine presented a temperature excursion at -14.3 degrees Celsius (C) for a timeframe of 1 hour and 14 minutes. There were no product quality complaints and no adverse events reported. ; Sender Comments: Keywords :  US-009507513-2306USA011972:
At 10 PM on 4/24/01, pt had nausea, vomiting, diarrhea and fever of 100-101. She was improved by 1 PM on 4/25/01.
pt recv vax 10SEP & 11SEP98 pt exp an excessive hematoma from the deltoid to elbow;
Patient was in Clinic for appointment, administrated HEP A for pediatric instead of Adult dose. Called CDC for further advice for valid or invalid dosing.
2 cm x 1 cm firm, red, warm area (Lt) thigh (+) fever (T 100.7); area increased in size on 6/13/13.
attenuated chickenpox 17FEB97 recv chickenpox vax JUL95;
Hospice services in place. Passed Away at 1923 on 6/29/22
Several days after receiving the vaccine, on 2/12, my mom started having intense itching at the injection site and soon after developed a rash on the arms, trunk and legs. She treated at home with benedryl and hydrocortisone.  On 2/13 she continued to have itching/rash and also developed a welt at the injection site. She visited the urgent care where she had an elevated blood pressure of 210/100 and 170/90. As an ICU nurse, I can attest that my mother?s blood pressure always runs in the 90s-100 systolic range. She received an injection of solumedrol and Benadryl orally and was given a prescription for prednisone for 3 days total.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patient was inadvertently vaccinated with an expired dose of GARDASIL as prophylaxis (Strength, dose, route, lot # and expiration date were not reported). No adverse effects were reported.
Information has been received form a physician concerning a 30 day old white male who was a premature baby who on 04-Sep- 2002 was vaccinated with a first dose of hepatitis Ba virus vaccine rHBsAg (yeast) (manufacturer unknown). Subsequently the patient experienced swelling and redness at the site. It was also noted that the patient developed adverse events after vaccination with varicella virus vaccine live (Oka/Merk) (MSD) (WAES # 0606USA02200)
Pt vaccinated with DTP/OPV developed episode of paleness w/color change w/circumoral cyanosis & blueness of lower extremities to knees assoc inc HR & trembling fever 103.6
1st dose of primary series with Moderna Covid-19 vaccine. At another practice, same patient received Pfizer Monovalent as 2nd dose.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (1st dose of primary series with Moderna Covid-19 vaccine. At another practice, same patient received Pfizer Monovalent as 2nd dose.) and NO ADVERSE EVENT (No adverse event) in a 7-month-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (1st dose of primary series with Moderna Covid-19 vaccine. At another practice, same patient received Pfizer Monovalent as 2nd dose.) and NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (1st dose of primary series with Moderna Covid-19 vaccine. At another practice, same patient received Pfizer Monovalent as 2nd dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INTERCHANGE OF VACCINE PRODUCTS (1st dose of primary series with Moderna Covid-19 vaccine. At another practice, same patient received Pfizer Monovalent as 2nd dose.).    No concomitant medication was reported. No treatment medication was reported.
Ipol was stored at the highest temperature 12.3 degrees C and total excursion time was 25 minutes, product was opened and was given a vaccine 24 hours after the excursion/ No AE; Initial information was received on 09-Jun-2020 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 11 weeks old (11 weeks 3 days) male patient who was vaccinated with the dose of suspect IPV (VERO) [IPOL] which was stored at the highest temperature 12.3 degrees C and total excursion time was 25 minutes, product was opened and was given a vaccine 24 hours after the excursion (product storage error)  The patient's medical history, past medical treatment, vaccination, and family history were not provided.  Concomitant medications included HIB VACCINE (HIB VACCINE); PNEUMOCOCCAL VACCINE 13V (PNEUMOCOCCAL 13 VALENT VACCINE) and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for prophylactic vaccination given on 13-May-2020.  On 13-May-2020, the patient received a 0.5 mL dose of suspect IPV (VERO) (lot P1F541M and expiry date 07-Dec-2020) via unknown route at an unknown administration site for prophylactic vaccination.  It was of actual medication error due to incorrect product storage.  case details: the reporter called know the stability data of Ipol vaccine. Reporter stated that that the patient received an IPOL dose from a multidose vial that had been out of range as the refrigerator was turn off.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directiveand Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Fatigue (4/2- 4/4), Fever of 102 (4/2 - 4/3 overnight for ~5-6 hours), extreme pain in injection arm (4/3 - 4/3 overnight for `5-6 hours, rash at injection site (4/3 - 4/5), loss os appetite (4/3 - 4/5), headache (4/22/ -4/4) and selling at and at least 6 inches outside of injection site.  Difficulty sleeping.
This spontaneous report as received from a father of the patient via a company representative refers to a 21 year old female patient. Concomitant medication, pertinent medical history, drug reactions and allergies were unknown. The patient was not pregnant. About five years ago, approximately in 2011, the patient was vaccinated with a dose of GARDASIL (dose, route of administration, lot # and expiration date were unknown). The patient was admitted to the hospital either 15-JUL-2016 or 16-JUL-2016, for tachycardia after receiving GARDASIL. A tilt test, an electrocardiography (EKG), and a stress test were performed, but results were not provided. The patient received a pacemaker on 18-JUL-2016. It was confirmed that the patient was vaccinated with GARDASIL and not GARDASIL 9. The outcome of tachycardia was unknown. The relationship between tachycardia and GARDASIL was not reported. The event of tachycardia was considered to be medically significant as required cardiac pacemaker insertion. Additional information has been requested.
Initially, inability to move/bend knee joints in both legs greatly hindered ability to walk. Muscle pain throughout back of legs from hamstrings down through calves. Stretching did not alleviate condition. After three days, condition in left leg lessened but remains in right leg to a lesser degree. It is now approximately 2 weeks after the second vaccination and still have stiffness and pain in right knee.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: Patient has vasovagal and experiences syncope somewhat regularly. 911 was called when she did not immediately regain consciousness, however she came to within 1-2 minutes. After 45 minutes of rest, reporting she felt normal again and being evaluated by EMTs she was cleared to leave on her own.
I experienced vision problems (spotted and blurred), sexual problems, chest and arm pain, balance problems and dizziness.
Normal shot soreness started that afternoon and lasted for 3 days.  Then around Nov 1 or 2, 2016 started having pain with moving left arm when taking off shirt or putting on seat belt and  would have shooting pain with this activity. Couldn't bear weight on left arm when lying down.
In 7/99, the pt developed varicella and sought unspecified medical attention. No further information is available.
Had EKG at hospital on 19 April in preparation for upcoming surgery.  Had a major dizzy spell once getting up from the EKG.  Dizzy spell lasted all day.  Had another big dizzy spell on the 25th of April.  Went to Doctor about Dizzy spells and she thought it was vertigo and prescribed Meclizine 25 mg to be taken by mouth 3 times daily as needed. Also  contacted Dr office and nurse navigator who was handling the surgery about dizzy spells.  They didn't think it would be a problem to go ahead with surgery.
3-4 months out from the first dose and have not yet received the second dose.; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3-4 months out from the first dose and have not yet received the second dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history were reported.     On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3-4 months out from the first dose and have not yet received the second dose.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3-4 months out from the first dose and have not yet received the second dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment information not provided. No lab data has been provided by the reporter.